4DX Ventures

4DX Ventures is a New York-headquartered, pan-Africa-focused VC firm investing across what it describes as the big four African markets in B2B e-commerce, healthcare, and logistics. Stage focus is seed and Series A with checks in the $1M to $5M range, and AI is not flagged as a primary focus. The US headquarters with African focus is a deliberate structural choice that gives the fund access to US LP capital and downstream syndicate networks while operating with deep on-the-ground African deal flow. Healthcare interest centers on digital health and tech-enabled care delivery across Nigeria, Kenya, Egypt, and South Africa. The right founder for 4DX is a pan-African operator, often a returnee or diaspora founder, building a digital health, healthcare commerce, or care delivery platform with credible scale potential across multiple African markets and the operational sophistication to manage cross-border execution. The wrong founder is a deep medtech or therapeutics team, a US-modeled SaaS company without African market thesis, or a hyper-local single-country business without continental ambition. Intro paths run through Lagos, Nairobi, Cairo, and Cape Town operator networks, frequent co-investors including Future Africa, P1 Ventures, Partech Africa, TLcom, Endeavor Catalyst, and global investors including Tiger Global, General Catalyst, and Quona Capital, and through 4DX’s own portfolio CEOs many of whom are publicly active. The US-Africa diaspora professional network including the YC Africa cohort and other top-tier accelerator alumni is also a strong intro vector. In the pitch, lead with cohort retention, real revenue, and cross-border execution evidence, the unit economics in local currencies with realistic FX assumptions, and a credible regulatory map across NAFDAC, KMPDC, EDA, and HPCSA as relevant. Show that you understand the operational complexity of multi-country African scaling including hiring, payments infrastructure, and regulatory licensing. Be specific about your data infrastructure given the patchwork of data protection regimes across African markets. Caveats include the persistent follow-on challenge for African Series B and beyond, the FX volatility that has reshaped unit economics in primary markets, and the reality that 4DX’s check size positions the fund as a syndicate participant rather than a sole lead at competitive Series A valuations. For pan-African healthcare operators with execution depth, the fit is strong.